RepliCel Capital Stock from 2010 to 2024
| RP Stock | CAD 0.01 0.00 0.00% |
Capital Stock | First Reported 2010-12-31 | Previous Quarter 36.4 M | Current Value 32.6 M | Quarterly Volatility 2.2 M |
Check RepliCel Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RepliCel Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 K, Interest Expense of 156.6 K or Other Operating Expenses of 2.7 M, as well as many indicators such as Price To Sales Ratio of 10.34, Dividend Yield of 0.0 or Days Sales Outstanding of 34.68. RepliCel financial statements analysis is a perfect complement when working with RepliCel Life Valuation or Volatility modules.
RepliCel | Capital Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.